Monthly Archive: January 2015

Jan 31

The full implementation of the Eighth Joint National Committee (JNC 8)

The full implementation of the Eighth Joint National Committee (JNC 8) guidelines for the management of adult hypertension could prevent approximately 56 000 cardiovascular events and 13 000 deaths each year in the US, without increasing costs to the healthcare system, points a new analysis published January 28 in the New England Journal of Medicine.

Jan 28

Fifty-five-year-olds who had prolonged moderately elevated non–HDL-cholesterol levels (>160 mg/dL)

Fifty-five-year-olds who had prolonged moderately elevated non–HDL-cholesterol levels (>160 mg/dL) when they were young adults had higher odds than their peers to have coronary heart disease by the time they were 70, suggested an analysis based on the Framingham Offspring Cohort, published online January 26 in Circulation.

Jan 22

Healthy middle-aged and older adults who are hospitalized for pneumonia tend to have an increased risk for cardiovascular disease (MI, stroke, or death from CVD)

Healthy middle-aged and older adults who are hospitalized for pneumonia tend to have an increased risk for cardiovascular disease (MI, stroke, or death from CVD) years later, pointed a new study published in the January 20 issue of the Journal of the American Medical Association.

Jan 15

Statin benefits in reducing major vascular events are about the same in women as in men when adjusted for predicted cardiovascular risk,

Statin benefits in reducing major vascular events are about the same in women as in men when adjusted for predicted cardiovascular risk, suggests a large meta-analysis published online in the Lancet.

Jan 14

A diet high in fat and exposure to certain bacteria, including Porphyromonas gingivalis and Chlamydia pneumoniae

A diet high in fat and exposure to certain bacteria, including Porphyromonas gingivalis and Chlamydia pneumoniae, alter distinct gene pathways and cause atherosclerosis, suggests a new study published in BMC Genomics.

Jan 13

A new technique, developed by researchers at The University of Manchester

A new technique, developed by researchers at The University of Manchester, may help surgeons find the exact location of heart defects and save lives and help them to treat patients more effectively by allowing non-invasive detection of the origin of heart problems. The report is published in PLoS Computational Biology.

Jan 12

Older Medicare patients with heart failure and reduced ejection fraction (HFrEF)

Older Medicare patients with heart failure and reduced ejection fraction (HFrEF) who were hospitalized for acute decompensation and were started on beta–blockers when they were discharged did not have worse 30–day readmission rates than those who were not given these drugs, suggests a new study published online in the American Journal of Medicine.

Jan 10

Declines in activity level as measured by accelerometer predicted deterioration in scores on tests of attention and executive function

Declines in activity level as measured by accelerometer predicted deterioration in scores on tests of attention and executive function over just 12 weeks in a mixed population with reduced- or preserved-ejection-fraction heart failure (HF), suggests new research published January 5 in the Journal of Cardiac Failure.

Jan 09

Early treatment with the aldosterone antagonist eplerenone plus an angiotensin-converting enzyme inhibitor (ACEI)

Early treatment with the aldosterone antagonist eplerenone plus an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin-receptor blocker (ARB) slows the progression of cardiomyopathy in boys with Duchenne muscular dystrophy, reported a new randomized trial published in Lancet Neurology.

Jan 09

Early treatment with the aldosterone antagonist eplerenone plus an angiotensin-converting enzyme inhibitor (ACEI)

Early treatment with the aldosterone antagonist eplerenone plus an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin-receptor blocker (ARB) slows the progression of cardiomyopathy in boys with Duchenne muscular dystrophy, reported a new randomized trial published in Lancet Neurology.

Older posts «